Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the immune response and safety of a respiratory syncytial virus vaccine given alone or co-administered with an adjuvanted influenza vac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Influenza vaccine, adjuvanted (Influenza vaccine with adjuvant)
• RSV vaccine (respiratory syncytial virus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2024-03-15